Abstract
Since becoming clinically available in 2011, the use of noninvasive prenatal testing (NIPT) to screen for fetal aneuploidy has continued to increase. However, it has been questioned whether the education of patients undergoing NIPT consistently meets informed consent standards. We sought to evaluate patients’ basic understanding of NIPT, such as conditions assessed and accuracy. In addition, we investigated patient self-assessment of NIPT knowledge and satisfaction with the testing process. We distributed an anonymous paper survey to pregnant women during prenatal visits following a negative NIPT result. The survey assessed patient NIPT knowledge, gathered pregnancy-specific and demographic information, and allowed respondents to rank their basic understanding of NIPT and provide written feedback about the testing process. A total of 95 completed and 3 partially completed surveys were returned. Participants scored lowest on knowledge questions involving whether a negative NIPT result ensures a healthy baby or eliminates the possibility of Down syndrome. Most perceived themselves to have a good basic understanding of NIPT and two-thirds of the written feedback proposed no changes to NIPT administration. Overall, most patients appear satisfied with their understanding of NIPT and the testing process, yet they may not fully appreciate the limitations of this screening method.
Similar content being viewed by others
Notes
NIPT is also referred to as noninvasive prenatal screening (NIPS) and cell-free fetal DNA testing for aneuploidy
Survey available upon request from the authors
References
ACOG. (2007). Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstetrics & Gynecology, 109, 217–227.
ACOG. (2012). Noninvasive prenatal testing for fetal aneuploidy. Committee Opinion No. 545. Obstetrics & Gynecology, 120, 1532–1534.
ACOG. (2015). Cell-free DNA screening for fetal aneuploidy. Committee Opinion No. 640. Obstetrics & Gynecology, 126(3), e31–e37.
Agatisa, P. K., Mercer, M. B., Leek, A. C., Smith, M. B., Philipson, E., & Farrell, R. M. (2015). A first look at women’s perspectives on noninvasive prenatal testing to detect sex chromosome aneuploidies and microdeletion syndromes. Prenatal Diagnosis, 35(7), 692–698.
Ames, A. G., Metcalfe, S. A., Dalton Archibald, A., Duncan, R. E., & Emery, J. (2015). Measuring informed choice in population-based reproductive genetic screening: a systematic review. European Journal of Human Genetics, 23(1), 8–21.
Benn, P., Cuckle, H., & Pergament, E. (2013). Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound in Obstetrics & Gynecology, 42, 15–33.
Bianchi, D. W., & Wilkins-Haug, L. (2014). Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road? Clinical Chemistry, 60(1), 78–87.
Bryant, A. S., Norton, M. E., Nakagawa, S., Bishop, J. T., Pena, S., Gregorich, S. E., & Kuppermann, M. (2015). Variation in women’s understanding of prenatal testing. Obstetrics & Gynecology, 125(6), 1306–1312.
Buchanan, A., Sachs, A., Toler, T., & Tsipis, J. (2014). NIPT: current utilization and implications for the future of prenatal genetic counseling. Prenatal Diagnosis, 34, 850–857.
Cho, R. N., Plunkett, B. A., Wolf, M. S., Simon, C. E., & Grobman, W. A. (2007). Health literacy and patient understanding of screening tests for aneuploidy and neural tube defects. Prenatal Diagnosis, 27(5), 463–467.
Devers, P. L., Cronister, A., Ormond, K. E., Facio, F., Brasington, C. K., & Flodman, P. (2013). Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the national society of genetic counselors. Journal of Genetic Counseling, 22, 291–295.
Dickens, B. M. (2013). Ethical and legal aspects of noninvasive prenatal genetic diagnosis. International Journal of Gynecology & Obstetrics, 124, 181–184.
Dormandy, E., Michie, S., Hooper, R., & Marteau, T. M. (2006). Informed choice in antenatal Down syndrome screening: a cluster-randomized trial of combined versus separate visit teaching. Patient Education and Counseling, 61(1), 56–64.
Farrell, R., Hawkins, A., Barragan, D., Hudgins, L., & Taylor, J. (2015). Knowledge, understanding, and uptake of noninvasive prenatal testing among Latina women. Prenatal Diagnosis, 35(8), 748–753.
Glazier, R., Goel, V., Holzapfel, S., Summers, A., Pugh, P., & Yeung, M. (1997). Written patient information about triple-marker screening: a randomized, controlled trial. Obstetrics and Gynecology, 90(5), 769–774.
Goel, V., Glazier, R., Holzapfel, S., Pugh, P., & Summers, A. (1996). Evaluating patient’s knowledge of maternal serum screening. Prenatal Diagnosis, 16, 425–430.
Gourounti, K., & Sandall, J. (2008). Do pregnant women in Greece make informed choices about antenatal screening for down’s syndrome? A questionnaire survey. Midwifery, 24(2), 153–162.
Gregg, A. R., Gross, S. J., Best, R. G., Monaghan, K. G., Bajaj, K., Skotko, B. G., et al. (2013). ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genetics in Medicine, 15(5), 395–398.
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009). Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381.
Jong, A. D., Maya, I., & Van Lith, J. M. M. (2015). Prenatal screening: current practice, new developments, ethical challenges. Bioethics, 29(1), 1–8.
Kohut, R. J., Dewey, D., & Love, E. J. (2002). Women’s knowledge of prenatal ultrasound and informed choice. Journal of Genetic Counseling, 11(4), 265–276.
Kuppermann, M., Pena, S., Bishop, J. T., Nakagawa, S., Gregorich, S. E., Sit, A., et al. (2014). Effect of enhanced information, values clarification, and removal of financial barriers on use of prenatal genetic testing: a randomized clinical trial. JAMA, 312(12), 1210–1217.
Lewis, C., Slicock, C., & Chitty, L. S. (2013). Non-invasive prenatal testing for Down’s syndrome: pregnant women’s views and likely uptake. Public Health Genomics, 16, 223–232.
Lewis, C., Hill, M., Skirton, H. & Chitty, L.S. (2015). Development and validation of a measure of informed choice for women undergoing non-invasive prenatal testing for aneuploidy. European Journal of Human Genetics.
Lo, Y. M. D., Corbetta, N., Chamberlain, P. F., Rai, V., Sargent, I. L., Redman, C. W. G., et al. (1997). Presence of fetal DNA in maternal plasma and serum. The Lancet, 350, 485–487.
Lo, J. O., Feist, C. D., Norton, M. E., & Caughey, A. B. (2014). Noninvasive prenatal testing. Obstetrical & Gynecological Survey, 69(2), 89–99.
Marteau, T. M., Dormandy, E., & Michie, S. (2001). A measure of informed choice. Health Expectations, 4(2), 99–108.
Mercer, M. B., Agatisa, P. K., & Farrell, R. M. (2014). What patients are reading about noninvasive prenatal testing: and evaluation of Internet content and implications for patient-centered care. Prenatal Diagnosis, 34, 986–993.
Nicolaides, K. H., Syngelaki, A., Gil, M., Atanasova, V., & Markova, D. (2013). Validating of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Prenatal Diagnosis, 33, 575–579.
Norton, M. E., & Rink, B. D. (2016). Changing indications for invasive testing in an eral of improved screening. Seminars in Perinatology, 40(1), 56–66.
Norton, M. E., Brar, H., Weiss, J., Karimi, A., Laurent, L. C., Caughey, A. B., et al. (2012). Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. American Journal of Obstetrics & Gynecology, 207, 137e1Y137e8.
Norton, M. E., Rose, N. C., & Benn, P. (2013). Noninvasive prenatal testing for fetal aneuploidy: clinical assessment and a plea for restraint. Obstetrics & Gynecology, 121(4), 847–850.
Patton, M. Q. (2001). Qualitative evaluation and research methods (p. 2001). Thousand Oaks: Sage.
Pettit, K., Hull, A. D., Korty, L., Jones, M. C., & Pretorius, D. H. (2014). The utilization of circulating cell-free fetal DNA testing and decreases in invasive diagnostic procedures: an institutional experience. Journal of Perinatology, 34(10), 750–753.
Rink, B. D., & Norton, M. E. (2016). Screening for fetal aneupoidy. Seminars in Perinatology, 40(1), 35–43.
Robinson, C., Van Den Boom, D., & Bombard, A. T. (2014). Noninvasive prenatal detection of aneuploidy. Clinical Obstetrics and Gynecology, 57(1), 210–225.
Rowe, H. J., Fisher, J. R., & Quinlivan, J. A. (2006). Are pregnant Australian women well informed about prenatal genetic screening? A systematic investigation using the multidimensional measure of informed choice. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 46(5), 433–439.
Swaney, P., Hardisty, E., Sayres, L., Wiegand, S., & Vora, N. (2016). Attitudes and knowledge of maternal fetal medicine fellows regarding noninvase prentatal testing. Journal of Genetic Counseling, 25(1), 73–78.
van den Bergh, M., Timmermans, D. R., ten Kate, L. P., van Vugt, J. M. G., & van der Wal, G. (2005). Are pregnant women making informed choices about prenatal screening? Genetics in Medicine: Official Journal of the American College of Medical Genetics, 7(5), 332–338.
Wagner, A. J., Mitchell, M. E., & Tomita-Mitchell, A. (2014). Use of cell-free fetal DNA in Maternal plasma for noninvasive prenatal screening. Clinical Perinatology, 41, 957–966.
Wax, J. R., Cartin, A., Chard, R., Lucas, F. L., & Pinette, M. G. (2014). Noninvasive prenatal testing: impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection. Journal of Clinical Ultrasound, 43(1), 1–6.
Yee, L. M., Wolf, M., Mullen, R., Bergeron, A. R., Bailey, S. C., Levine, R., et al. (2014). A randomized trial of a prenatal genetic testing interactive computerized information aid. Prenatal Diagnosis, 34(6), 552–557.
Acknowledgments
This study was completed in partial fulfillment of the requirements for the first author’s Master of Science degree. The authors would like to thank the staff at the participating centers for their feedback on survey drafts and their assistance in survey distribution. The authors would also like to thank the survey participants for their time and willingness to contribute to this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Authors Julie L. Piechan, Karrie A. Hines, Kristyne Stone, Daniel L. Koller, Kimberly Quaid, Wilfredo Torres-Martinez, Divya Wilson Mathews, Tatiana Foroud, and Lola Cook declare that they have no conflict of interest.
Human Studies and Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients to be included in the study.
Animal Studies
No animal studies were carried out by the authors for this article.
Rights and permissions
About this article
Cite this article
Piechan, J.L., Hines, K.A., Koller, D.L. et al. NIPT and Informed Consent: an Assessment of Patient Understanding of a Negative NIPT Result. J Genet Counsel 25, 1127–1137 (2016). https://doi.org/10.1007/s10897-016-9945-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-016-9945-x